FCA
ABMD

FinTrust Capital Advisors’s Abiomed Inc ABMD Stock Holding History

FinTrust Capital Advisors’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-50
Closed -$16K – 1187
2020
Q4 		$16K Hold
50
– – 0.01% 729
2020
Q3 		$14 Buy
50
+34
+213% +$9.79K ﹤0.01% 730
2020
Q2 		$4K Hold
16
– – ﹤0.01% 867
2020
Q1 		$2K Buy
16
+11
+220% +$1.83K ﹤0.01% 1040
2019
Q4 		$1K Sell
5
-4
-44% -$742 ﹤0.01% 1058
2019
Q3 		$2K Buy
9
+2
+29% +$432 ﹤0.01% 1011
2019
Q2 		$2K Sell
7
-1
-13% -$265 ﹤0.01% 979
2019
Q1 		$2K Sell
8
-10
-56% -$3.32K ﹤0.01% 1144
2018
Q4 		$6K Buy
+18
New +$6.25K ﹤0.01% 902

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

FinTrust Capital Advisors's ABMD Position: Q1 2021 in Review

FinTrust Capital Advisors sold out of Abiomed Inc (ABMD) in Q1 2021, closing a stake of 50 shares — an estimated $16K sold.

FinTrust Capital Advisors first reported a position in ABMD in Q4 2018 and held it in 9 quarters. The position peaked at $16K in Q4 2020. 487 funds tracked by Wall St. Rank hold ABMD as of Q1 2021.

  • FinTrust Capital Advisors reported no remaining Abiomed Inc position as of Q1 2021 after selling out during the quarter.
  • FinTrust Capital Advisors sold 50 Abiomed Inc shares in Q1 2021, an estimated $16K.
  • FinTrust Capital Advisors first reported a position in Abiomed Inc in Q4 2018 and held it in 9 quarters.
  • FinTrust Capital Advisors's Abiomed Inc position peaked at $16K in Q4 2020.
  • 487 funds tracked by Wall St. Rank held Abiomed Inc as of Q1 2021.

Based on FinTrust Capital Advisors's 13F filing for Q1 2021, filed 17 May 2021.